In osteosarcoma, miR-203 markedly inhibited cancer cell growth, invasion, migration, and suppressed mesenchymal-toepithelial reversion transition (MErT) through targeting RAB22A or TBK1 [28,29]. The gene discussed is RAB22A; the disease is osteosarcoma.